Fresh Start has a new product using an FDA approved drug in the treatment of alcoholism. The Company's research has indicated that demand for its services are high, and that growth in highly marketed segments of the population may be achieved through additional clinic sites.
Fresh Start Private's goal is to meet its growth targets through franchising opportunities by promoting its product and services to existing medical clinics and treatment centers that will be will be charged a franchise fee and a percentage of sales.
As well, the Company intends to also open corporately owned clinics in key markets where it has already established a foothold on the industry.
We have the expertise in management, a great product and a strong demand for our services. We want our clients to be the stars of their lives again, and get a Fresh Start with our program. That's what we do.
Please download our latest investor briefings here
COMPANY STRUCTURE DETAILS
Legal name: Fresh Start Private Management Inc.
Sector: Healthcare
Industry: Specialized Health Services
Full Time Employees: 12
Public Company: SEC Reporting and fully audited
Symbol: CEYY
Exchange: OTCBB
Outstanding: 75.4 million
Authorized: 200,000,000
CUSIP: 35804J102
NAICS Code: 623220
SIC Number: 8361
Transfer Agent: Delos Stock Transfer, 762 South U.S. Highway 1, Suite 159, Vero Beach, Florida 32962
delosstocktransfer@gmail.com
CIK: 0001407343
EIN: 26-3550286
Year End: November 30
State of incorporation: Nevada
Products: Alcohol Rehabilitation, patented Naltrexone Implant technology
Address: 999 N. Tustin Ave Suite 16, Santa Ana, Ca, 92705 USA
Investors: 949.209.8964
Email: ir@freshstartprivate.com
Website: www.freshstartprivate.com
KEY EXECUTIVES
Dr, Jorge Andrade Jr. - CEO
Mr. Neil Muller - President